Microbiome Drug Discovery

Circle Oncodesign Services

Deciphering the Microbiome’s role in drug discovery with an experienced CRO



Why studying and understanding the human microbiome is important in drug discovery?


The human microbiome refers to the trillions of microorganisms, including bacteria, viruses, fungi, and archaea, that inhabit various regions of the body, such as the gastrointestinal tract, skin, oral cavity, and more. Having a profound influence on human health and disease but also on efficiency of non-microbial drugs, taking the human microbiome into account is becoming crucial for the development of innovative therapies.

Efforts were made to harness the microbiome for diagnostic and prophylactic/therapeutic purposes. The microbiome research can include:

  • Study the relationship between microbiome composition and the disease of interest
  • Evaluation of microbiome therapeutics
  • Definition of the role of microbiome in precision diagnosis and personalized treatment
  • Understanding the impact of a drug on microbiome & the influence of microbiome on individual’s response to a drug


In vitro assays - Oncodesign Services

Harnessing the microbiome in drug discovery with Oncodesign Services


Oncodesign Services has developed a comprehensive platform to demonstrate the benefit on health, to assess safety and/or to decipher mechanism(s) of action of microbiome-based therapeutics or non-microbial drugs.

We use a broad range of technological approaches for culturing, detecting, identifying and localizing microorganisms (bacteria, yeasts, etc.) in simple or complex samples (fluids, tissues) coming from preclinical studies or clinical trials.


Microbiome preclinical research


Discover our customized solutions focusing on microbiome-based therapeutics and/or drug-microbiome interactions.